TY  - JOUR
AU  - Lawson, Kim
PY  - 2020
DA  - 2020/01/20
TI  - Sleep Dysfunction in Fibromyalgia and Therapeutic Approach Options
JO  - OBM Neurobiology
SP  - 049
VL  - 04
IS  - 01
AB  - Fibromyalgia, characterised by persistent pain, sleep disturbance, fatigue and cognitive dysfunction, is a central sensitivity syndrome that also involves abnormality in peripheral generators and in the hypothalamic pituitary adrenal axis. Heterogeneity of clinical expression of fibromyalgia with a multifactorial aetiology has made the development of effective therapeutic strategies challenging. Non-restorative sleep associated with poor sleep quality is a characteristic of fibromyalgia which is linked to symptom severity. A relationship between sleep disorder and central sensitization could be a possible factor involved in development, exacerbation and/or maintenance of fibromyalgia. Association between disordered sleep and the risk of fibromyalgia suggests that limiting sleep problems would reduce the incidence of the condition. Therapeutic approaches with treatments that consolidate or deepen sleep may be preferential to improve sleep in patients with fibromyalgia. Thus, disordered sleep appears fundamental to the pathophysiology of fibromyalgia and as such the risk of sleep disturbances needs to be proactively assessed and when identified in this patient group be actively managed to improve health outcomes for patients with fibromyalgia.
SN  - 2573-4407
UR  - https://doi.org/10.21926/obm.neurobiol.2001049
DO  - 10.21926/obm.neurobiol.2001049
ID  - Lawson2020
ER  -